The United States Pharmacopeial Convention (USP) is a public charity based in Rockville, Maryland. It is a scientific organization that develops standards and science-based solutions intended to help increase the supply of quality medicines, dietary supplements, and food ingredients.
Key facts about United States Pharmacopeial Convention
In short: United States Pharmacopeial Convention gave $256K across 17 grants in 2025 (avg $15K), top state District of Columbia. 47% of 2025 grantees were new. Source: 2025 IRS Form 990.
- EIN
- 13-1656692
- Latest 990 filing
- Form 990, 2025
- Annual giving (2025)
- $256,437
- Grants made (2025)
- 17
- Average grant
- $15,085
- Median grant
- $10,000
- New grantees (estimate)
- 47% first-time grantees (8 of 17, 2025)
- Total assets
- $788,657,741
- Primary geography
- District of Columbia (37% of itemized 2025 grant dollars)
- How to apply
- The Next Generation Scientists program’s application window is closed. Full details ↓
Data from IRS Form 990, 2025; updated September 2026. New grantees are estimated by matching recipient names across years (methodology). Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Financial Overview
From 2025 IRS Form 990 · View filing
Total Assets
$788.7M
+5.0% YoY
Annual Giving
$256K
+1.6% YoY
Grant Count
17
+41.7% YoY
Avg Grant Size
$15K
-28.3% YoY
Is United States Pharmacopeial Convention open to new grantees?
47%
first-time grantees, 2025
In 2025, 8 of 17 grantees (47%) were first-time recipients. First grants averaged $15K; repeat grants $15K. How we count
Medians: $11K first-time, $10K repeat.
Estimate from itemized grant lists in IRS Form 990 filings (2020–2025). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Mission & Focus Areas
USP’s mission, as stated in its 2024 filing, is “to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.” Its website describes work on standards and science-based solutions for medicines, dietary supplements, and food ingredients.
USP’s Next Generation Scientists research grants support proposals in pharmaceutical medicines, dietary supplements, and foods that connect with quality or supply-chain issues and could benefit quality assurance or help USP create standards or products. The program evaluates strategic relevance, scientific merit, and novelty. USP also describes fellowship opportunities for graduate-level research aligned with its mission and strategic goals.
Examples of 2025 grant recipients illustrate a range of supported organizations. The Association for Accessible Medicines says it promotes the interests of the generic pharmaceutical and biosimilars industry. The American Pharmacists Association describes itself as a professional organization that equips pharmacists for patient-centered care. BioHealth Innovation says it connects research assets with funding, management, and markets to support commercially viable biohealth products and companies. Newark Mentoring Movement says it connects people and organizations with mentoring programs to support Newark’s youth. The Alliance for Aging Research says it works toward healthy aging and equitable access to care.
Grantmaking
In filing year 2025, USP reported 17 grants totaling $256,437. Grants ranged from $6,000 to $32,700, with a median of $10,000. The largest listed grants included $32,700 to the Association for Accessible Medicines for sponsorship of AAM 2024 GRX+ BIOSIMS; $27,737 to the American Pharmacists Association for sponsorship of its 2025 annual meeting; and $25,000 each to Project HOPE for an inaugural charity golf tournament sponsorship and BioHealth Innovation for a charitable donation. Other listed awards included $20,000 to Newark Mentoring Movement and $15,000 to the Reagan-Udall Foundation for the FDA for sponsorship of its annual Innovations in Regulatory Science Awards.
Ready to take the next step with United States Pharmacopeial Convention?
Geographic Focus
Where this funder awards grants
USP is based in Rockville, Maryland. In 2025, the largest shares of grant dollars went to recipients in Washington, DC (37%), Maryland (18%), and Virginia (17%), followed by New Jersey (8%) and New York (5%). These figures describe the locations of 2025 grant recipients.
Grant Distribution by State
Share of all 17 itemized 2025 grant dollars.
States
Cities
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2025, annual grant giving ranged from $227K (2021) to $662K (2022). In 2025 it made 17 grants totaling $256K.
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2025
The largest 2025 recipient was Association for Accessible Medicines ($33K). Together the top 10 received $197K.
Grant Size Distribution
62 grants across all recorded years
The most common grant size was under $50K: 58 grants of 62 (94%).
Giving History
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Association for Accessible Medicines Washington, DC | Sponsorship - Aam 2024 GRX+ Biosims | $32,700 |
| American Pharmacists Association Washington, DC | Apha 2025 Annual Meeting - Sponsorship | $27,737 |
| Project Hope Millwood, VA | Inaugural Charity Golf Tournament Sponsorship | $25,000 |
| Biohealth Innovation Inc Rockville, MD | Charitable Donation | $25,000 |
| Newark Mentoring Movement Newark, NJ | Newark Mentoring Movement | $20,000 |
| George Washington's Mount Vernon Mount Vernon, VA | Charitable Donation | $19,500 |
| Reagan Udall Foundation for the Food and Drug Administration Inc Washington, DC | Annual Innovations in Regulatory Science Awards - Sponsorship | $15,000 |
| Worldwide Business Research USA LLC New York, NY | Logipharma US 2024 Meeting - Sponsorship | $12,000 |
| Alliance for Aging Research Washington, DC | Annual Dinner Sponsorship | $10,000 |
| Consumer Health Products Association Washington, DC | Platinum Level Sponsorship | $10,000 |
Financial History
Multi-year comparison from IRS filings
| Filing year | Assets | Revenue | Expenses | Grants |
|---|---|---|---|---|
| 2025 | $788,657,741 | $357,720,644 | $333,614,948 | $256,437 (17) |
| 2024 | $750,835,911 | $353,749,327 | $330,337,653 | $252,498 (12) |
| 2023 | $701,768,432 | $346,271,530 | $313,280,612 | $268,062 (12) |
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $788,657,741 | $750,835,911 | $701,768,432 |
| Revenue | $357,720,644 | $353,749,327 | $346,271,530 |
| Expenses | $333,614,948 | $330,337,653 | $313,280,612 |
| Net Investment Income | $21,655,407 | $10,536,524 | $10,363,719 |
Data update history
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS November 16, 2020)
- IRS filings on file for fiscal years 2020–2025
Leadership & Key People
Leadership team and compensation from IRS filings
Officers and trustees listed on the 2025 filing include Dennis E. Doherty, MD, Convention President; Todd K. Abraham, PhD, MBA, Treasurer; Gregory E. Amidon, PhD, Pharmaceutical Sciences Trustee; Gwen Darien, Public Trustee; Richard J. Gilfillan, MD, MBA, At Large Trustee; Jesse L. Goodman, MD, MPH, Medical Sciences Trustee; Laura Herman, MBA, MA, At Large Trustee; Thomas Menighan, BPharm, MBA, At Large Trustee; Krishna Reddy Nallamalla, MD, At Large Trustee; and Stephen Ostroff, MD, Medical Sciences Trustee.
United States Pharmacopeial Convention is led by Ronald T. Piervincenzi, Chief Executive Officer & Ex-Officio since 2022 (on filings since 2020); 13 of 26 officers listed in 2025 are compensated.
Officers on the 2025 filing
Ronald T. Piervincenzi
Chief Executive Officer & Ex-Officio
Chief Executive Officer → Chief Executive Officer & Ex-Officio, 2022
On filings since 2020
38 hrs/week
$832K (2020) → $975K (2025)
Dennis E. Doherty MD
Convention President
President → Convention President, 2022
On filings since 2021
4 hrs/week
No compensation reported
Susan Winckler Rph JD
Chair & Pharma Sci Trustee
On filings since 2022
4 hrs/week
No compensation reported
Gregory E. Amidon PhD
Pharmaceutical Sciences Trustee
Pharmaceutical Trustee → Pharmaceutical Sciences Trustee, 2023
On filings since 2020
4 hrs/week
No compensation reported
Jesse L. Goodman MD MPH
Medical Sciences Trustee
President → Medical Sciences Trustee, 2021
On filings since 2020
4 hrs/week
No compensation reported
Laura Herman Mba Ma
At Large Trustee
Public Trustee → At Large Trustee, 2021
On filings since 2020
4 hrs/week
No compensation reported
Gwen Darien
Public Trustee
On filings since 2021
4 hrs/week
No compensation reported
John Taylor JD
At Large Trustee
On filings since 2021
4 hrs/week
No compensation reported
Krishna Reddy Nallamalla MD
At Large Trustee
On filings since 2021
4 hrs/week
No compensation reported
Richard J. Gilfillan MD MBA
At Large Trustee
On filings since 2021
4 hrs/week
No compensation reported
Stephen Ostroff MD
Medical Sciences Trustee
On filings since 2021
4 hrs/week
No compensation reported
Julio Sanchez Y. Tepoz Mscsjd
At Large Trustee
On filings since 2022
4 hrs/week
No compensation reported
Thomas Menighan Bspharmmba
At Large Trustee
On filings since 2022
4 hrs/week
No compensation reported
Amanda D. Cowley
Senior Vice President, Legal, Strategy & People
General Counsel - → Senior Vice President Legal People Strategy, 2021
Senior Vice President Legal People Strategy → Senior Vice President, Legal, Strategy & People, 2025
On filings since 2020
38 hrs/week
$355K (2020) → $531K (2025)
Anthony P. Lakavage
Secretary & Senior Vice President Glbl Ea
Secretary → Senior Vice President Glbl Ea, 2022
Senior Vice President Glbl Ea → Secretary & Senior Vice President Glbl Ea, 2023
On filings since 2020
38 hrs/week
$415K (2020) → $545K (2025)
Emily M. Kaine
Senior Vice President, Gbl Health & Manufacturing Svcs
Senior Vice President & Global Health → Senior Vice President & Ghms, 2022
Senior Vice President & Ghms → Senior Vice President, Gbl Health & Manufacturing Svcs, 2024
On filings since 2020
38 hrs/week
$367K (2020) → $527K (2025)
Jennifer Devine
Senior Vice President, Doc Stds & Comp Policy
On filings since 2020
38 hrs/week
$329K (2020) → $419K (2025)
Stanley D. Burhans
Chief Financial Officer
Chief Financial Officer → Chief Financial Officer, Senior Vice President & Ops, 2024
Chief Financial Officer, Senior Vice President & Ops → Chief Financial Officer, 2025
On filings since 2020
38 hrs/week
$410K (2020) → $508K (2025)
Bruk Alemayehu
Senior Vice President, Global Lab & Technical Ops
Senior Vice President & Glto → Senior Vice President, Global Lab & Technical Ops, 2024
On filings since 2021
38 hrs/week
$352K (2021) → $430K (2025)
Michael S. Levy
Senior Vice President, Digital & Innovation
Senior Vice President, Dig & Innov → Senior Vice President, Digital & Innovation, 2023
On filings since 2022
38 hrs/week
$360K (2022) → $442K (2025)
Fouad Atouf
Senior Vice President & Sci-Glob Bio
On filings since 2023
38 hrs/week
$350K (2023) → $424K (2025)
Venkat Surendra Nath Koduru
Senior Vice President Regions & Program Ops.
On filings since 2023
38 hrs/week
$451K (2023) → $491K (2025)
Debra J. Perez
Chief Equity Officer
On filings since 2024
38 hrs/week
$411K (2024) → $450K (2025)
Jakob Venema To
Executive Vice President & Chief Science Officer
New on the 2025 filing
38 hrs/week
$619K (2025)
John A. Giannone To
Vice President & Compendial Operations
New on the 2025 filing
38 hrs/week
$552K (2025)
Todd K. Abraham PhD MBA
Treasurer
At-Large Trustee → Treasurer, 2021
On filings since 2020
4 hrs/week
No compensation reported
Former officers (27)
- Former: Jakob Venema (2020–2024) — Executive Vice President & Chief Science Officer
- Former: Kenneth B. Alexander - Vp Dep (2024) — Gc & Vice President Mng Aty Glb Lg Aff
- Former: Nurisha R. Wade - Vp Hqs Coe (2024) — Vice President & Industry Programs
- Former: Robert L. Anderson (2022–2023) — Vice President & Mktg Comms Executive
- Former: Dawn M. Oram (2023) — Head of Gpc
- Former: Deidre E. Boulware (2022) — Vice President & Global Hr
- Former: Kenneth B. Alexander (2022) — Vice President & Deputy Gc
- Former: Hermes Van Der Lee (2020–2021) — Senior Vice President & Global Lab Ops · Filing note: Ended 920
- Former: Salah D. Kivlighn (2020–2021) — Senior Vice President & Global Smpo · Filing note: Ended 5220
- Former: Adetokunbo J. Joseph (2021) — Vice President & Global Compliance Ethics · Filing note: Ended 720
- Former: John B. Atwater (2021) — Senior Director & Verification Programs · Filing note: Ended 7220
- Former: Julio Sanchez Y. Tepoz Mscs JD (2021) — At Large Trustee
- Former: Samir Z. Wahab (2021) — Vice President & Global Rsl · Filing note: Ended 7220
- Former: Susan Winckler Bs Pharmjdfa (2021) — Chair & Pharma Sci Trustee
- Former: Thomas Menighan Bspharm MBA (2021) — At Large Trustee
- Former: Ben A Firschein (2020) — Director, Gea Rsrch & Analysis
- Former: Christine Stunyo (2020) — Senior Vice President Global Human Resources
- Former: Gail R Wilensky PhD (2020) — At-Large Trustee
- Former: John E Courtney PhD (2020) — Treasurer
- Former: Marilyn K Speedie PH (2020) — Pharmaceutical Trustee
- Former: Paul Chew MD (2020) — Medical Sciences Trustee
- Former: Robert J Meyer MD (2020) — Medical Sciences Trustee
- Former: Satyanarayana Chava P (2020) — At-Large Trustee
- Former: Scott P Henderson (2020) — Senior Vice President, Info & Svcs -
- Former: Susan S De Mars (2020) — Frmr Chf. Legal Officer -
- Former: Susan Winckler BS PHA (2020) — Chair
- Former: Timothy R FransonBS (2020) — Past President
Data from IRS Form 990 filings, 2020–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $975K, to Ronald T Piervincenzi (Chief Executive Officer & Ex-Officio). 13 officers or directors reported compensation on that filing.
Contact
Mailing address: 12601 Twinbrook Parkway, Rockville, MD 20852
Phone: (301) 881-0666
Website: https://usp.org
Frequently asked questions about United States Pharmacopeial Convention
How much does United States Pharmacopeial Convention give each year?
United States Pharmacopeial Convention gave $256K across 17 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $252K across 12 grants.
What is United States Pharmacopeial Convention's typical grant size?
United States Pharmacopeial Convention's median grant in 2025 was $10,000, and its average grant was $15,085, across 17 grants on its 2025 IRS Form 990. Organizations receiving their first grant from United States Pharmacopeial Convention that year got $15K on average.
Where does United States Pharmacopeial Convention give grants?
United States Pharmacopeial Convention's top state is District of Columbia, with 37% of the grant dollars itemized on its 2025 IRS Form 990. The next largest states were Maryland (18%) and Virginia (17%). The most frequent recipient cities were Washington, DC (5 grants) and Rockville, MD (2 grants).
Does United States Pharmacopeial Convention give general operating support?
Not in 2025: none of the 17 grants with a stated purpose on United States Pharmacopeial Convention's 2025 IRS Form 990 were described as general or operating support.
Who are United States Pharmacopeial Convention's largest grantees?
United States Pharmacopeial Convention's largest 2025 grantees include Association for Accessible Medicines ($32,700), American Pharmacists Association ($27,737) and Project Hope ($25,000), according to its 2025 IRS Form 990. Together they received 33% of its itemized 2025 grant dollars.
How large is United States Pharmacopeial Convention?
United States Pharmacopeial Convention reported $788.7M in total assets on its 2025 IRS Form 990. Its revenue that year was $357.7M.
What does United States Pharmacopeial Convention fund?
USP’s mission, as stated in its 2024 filing, is “to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.” See mission & focus areas ↑
How do I apply for a grant from United States Pharmacopeial Convention?
The Next Generation Scientists program’s application window is closed. Eligibility and process details are in the grantmaking section of this profile. See how to apply ↑
What is United States Pharmacopeial Convention's EIN?
United States Pharmacopeial Convention's EIN (Employer Identification Number) is 13-1656692. IRS Form 990 filing data is available on this page for 2020–2025.
Data last updated September 2026. Sourced from IRS Form 990 filings. Research dossier generated September 2026.
Here's the math on researching United States Pharmacopeial Convention by hand.
Explore Open Grants
Browse active grant opportunities in United States Pharmacopeial Convention's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Pharmaceutical Research and Manufacturers of America
Washington, DC
PhRMA funds advocacy, public education, and health-related organizations and initiatives aligned with its biopharmaceutical policy goals; its 2024 grants had a median of $20,000, though amounts varied widely. Grants went mainly to organizations in Washington, DC, Connecticut, California, Virginia, and New York. The profile does not state whether it accepts unsolicited requests.
Assets
$349.0M
Grants
461
Total Given
$41.4M
Enterprise Holdings Foundation
Saint Louis, MO
Enterprise Holdings Foundation supports nonprofits in health, education, arts, disaster relief, reforestation, hunger relief, and community equity, with an emphasis on organizations actively supported by Enterprise employees and their families. Its reported grants range widely: 2024 giving averaged about $7,700 across 9,499 grants, while the foundation also offers awards of up to $40,000; it supports communities where Enterprise operates worldwide. Unsolicited requests are accepted at any time, but eligible applications must be submitted by an Enterprise team member or their spouse or domestic partner on behalf of a nonprofit they actively support.
Assets
$594.3M
Grants
1
Total Given
$101.4M
Bristol-Myers Squibb Foundation Inc
Princeton, NJ
The Bristol-Myers Squibb Foundation supports health-access initiatives for disproportionately affected populations, including cancer, blood disorders, brain health, and clinical-trial participation, in the United States and internationally. In 2024, its median grant was $134,090, though awards varied widely; it says application materials are available upon request and advises organizations to contact it about the process, but does not state whether unsolicited requests are accepted.
Assets
$83.3M
Grants
144
Total Given
$67.7M
Motorola Solutions Foundation
Chicago, IL
The Motorola Solutions Foundation funds first responder programs, technology and engineering education, and projects combining the two, with priority for under-resourced populations. Its 2025 grants had a median of $35,000; the 2026 cycle capped most requests at $50,000, and it supports organizations worldwide, prioritizing communities where Motorola Solutions operates and universities it recruits from. It accepts unsolicited letters of inquiry during its grant cycle, with full applications by invitation only.
Assets
$1.2M
Grants
213
Total Given
$12.6M
Annie E Casey Foundation Inc
Baltimore, MD
The Annie E. Casey Foundation funds U.S. nonprofits and other partners working to improve outcomes for children and young people, including family strengthening, child welfare, education, employment, community development and juvenile justice. In 2024, grants ranged from $50 to $1,185,000, with a median of $40,000. Grants are by invitation only; it does not accept unsolicited requests.
Assets
$2.3B
Grants
1,462
Total Given
$93.1M
The Harry and Jeanette Weinberg
Owings Mills, MD
The Harry and Jeanette Weinberg Foundation funds direct services, programs, general operations, and capital projects in housing, health, jobs, education, and aging for low-income and vulnerable people. Its 2024 grants had a median of $50,000; its Small Grants Program offers up to $50,000 over two years, with funding focused on Baltimore, Hawaiʻi, Israel, and Northeastern Pennsylvania. It awards grants by invitation only and does not accept unsolicited requests.
Assets
$1.8B
Grants
872
Total Given
$127.8M
Johns Hopkins University
Baltimore, MD
Johns Hopkins University funds education, research, clinical practice, and related programs, with many large awards listed as sub-awards; its 2025 grants had a median of $100,000. Grants went mainly to recipients in California and Maryland, among other states, but no geographic restriction or policy on unsolicited requests is stated.
Assets
$25.3B
Grants
813
Total Given
$594.1M
The Keith Campbell Foundation
Bethesda, MD
The Keith Campbell Foundation funds environmental work and more equitable, livable communities, including watershed advocacy, agriculture, drinking water, and water management, with a focus on California and the Chesapeake region and select counties in Maryland and Pennsylvania. Its 2024 grants ranged from $40 to $1.5 million, with a median of $5,000; it accepts unsolicited requests through two grant cycles each year, though prior grantees cannot apply through that process.
Assets
$420.2M
Grants
688
Total Given
$27.9M
Cystic Fibrosis Foundation
Bethesda, MD
The Cystic Fibrosis Foundation funds cystic fibrosis research, drug development, specialized care, and related community and patient-support programs, primarily through opportunities for academic and industry investigators. Its 2024 grants ranged from $2,800 to $12.9 million, with a median grant of about $150,000; the profile does not specify a geographic limit or whether it accepts unsolicited requests.
Assets
$5.0B
Grants
624
Total Given
$189.6M
Baltimore Community Foundation Inc
Baltimore, MD
Baltimore Community Foundation funds stronger schools and neighborhoods, including kindergarten readiness, student mental health, school climate, neighborhood improvement, and community development, primarily in Baltimore City and Baltimore County. In 2024 it made 604 grants totaling $29.3 million, with a median grant of about $19,800. It accepts applications for certain programs through its online portal.
Assets
$314.3M
Grants
604
Total Given
$29.3M
Associated Jewish Charities of Baltimore
Baltimore, MD
Associated Jewish Charities of Baltimore supports charitable, educational, religious, health, cultural, humanitarian, and social-service needs of the Jewish community locally, nationally, in Israel, and worldwide. Its 2025 grants ranged from $5,020 to $15,250,570, with a median of $18,750. The information describes grant recommendations by current fundholders but does not state whether unsolicited requests are accepted.
Assets
$446.7M
Grants
515
Total Given
$53.0M
Nora Roberts Foundation
Glenn Dale, MD
The Nora Roberts Foundation prioritizes literacy and also funds the arts, children, social justice, and the environment, supporting eligible public-serving nonprofits and programs across the United States, with priority for specified nearby counties and Washington, DC. Typical grants are about $5,000 for local groups and $3,000 for non-local groups; it recommends first-time applicants request $3,000–$5,000. Its 2024 filing says it does not accept unsolicited requests and gives only to preselected organizations, though its website describes an application process.
Assets
$118.6M
Grants
466
Total Given
$7.5M
More Funders in Maryland
United States Pharmacopeial Convention down — hundreds of funders to go?